CompletedNot Applicable

Focus on the Humeral Component Following Reverse Shoulder Arthroplasty

Belgium123 participantsStarted 2021-06-01

Plain-language summary

Reverse total shoulder arthroplasty has been widely used in the treatment of rotator cuff arthropathy. Follow-up has historically focused on the glenoid component because of problems with fixation and scapular notching leading to functional failure. Since several patients have shown cortical thinning of the proximal lateral humeral cortex during follow-up, further research is recommended to evaluate the cause and clinical impact of these radiographic changes. The goal of this study is to collect long-term radiographic and clinical data in order to facilitate the identification of risk factors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Minimum age of 18 years old * Total shoulder replacement using a reverse type implant (Delta Xtend or Zimmer TM) between 2007 and 2017 in UZ Leuven * Primary indication for surgery is rotator cuff arthropathy * Informed consent obtained Exclusion Criteria: * Total shoulder replacement in post septic arthritis. * Total shoulder replacement in post-instability arthritis. * Revision total shoulder arthroplasty. * Posttraumatic total shoulder arthroplasty (after failed index operation)

What they're measuring

Shoulder X-ray

Timeframe: up to 20 months

Trial details

NCT IDNCT04809077

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-01

View on ClinicalTrials.gov More Rotator Cuff Arthropathy trials